BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8660453)

  • 1. Iatrogenic neonatal hypertrophic cardiomyopathy.
    Gill AW; Warner G; Bull L
    Pediatr Cardiol; 1996; 17(5):335-9. PubMed ID: 8660453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy in preterm infants treated with dexamethasone.
    Miranda-Mallea J; Pérez-Verdú J; Gascó-Lacalle B; Sáez-Palacios JM; Fernández-Gilino C; Izquierdo-Macián I
    Eur J Pediatr; 1997 May; 156(5):394-6. PubMed ID: 9177985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].
    Boeuf B; Maragnes P; Belzic I; Lacotte J; Bonte JB; Guillois B
    Arch Pediatr; 1997 Feb; 4(2):152-7. PubMed ID: 9097827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone].
    Villa Alcázar M; Pellicer Martínez A; Burgueros Valero M; Quero Jiménez J
    An Esp Pediatr; 1996 Apr; 44(4):393-4. PubMed ID: 8796947
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
    Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
    Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
    Kale Y; Aydemir O; Ceylan O; Bas AY; Demirel N
    Pediatr Neonatol; 2015 Aug; 56(4):268-70. PubMed ID: 23639746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transient hypertrophic cardiomyopathy due to dexamethasone therapy in a premature infant].
    Pokela ML
    Duodecim; 1995; 111(14):1310-3. PubMed ID: 9244681
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants.
    Israel BA; Sherman FS; Guthrie RD
    Am J Perinatol; 1993 Jul; 10(4):307-10. PubMed ID: 8397569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible steroid-induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns.
    Haney I; Lachance C; van Doesburg NH; Fouron JC
    Am J Perinatol; 1995 Jul; 12(4):271-4. PubMed ID: 7575834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.
    Fritz KI; Bhat AM
    J Perinatol; 1998; 18(1):38-44. PubMed ID: 9527943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C; Bertini G; Simone P; Rubaltelli FF
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids.
    Yunis KA; Bitar FF; Hayek P; Mroueh SM; Mikati M
    Am J Perinatol; 1999; 16(1):17-21. PubMed ID: 10362077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertrophic cardiomyopathy in preterm newborn with kidney transplanted mother].
    Méndez-Abad P; Zafra-Rodríguez P
    Arch Argent Pediatr; 2018 Dec; 116(6):e749-e752. PubMed ID: 30457729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy with outflow tract obstruction-a complication of dexamethasone treatment for subglottic stenosis.
    Balys R; Manoukian J; Zalai C
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):271-3. PubMed ID: 15656964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.
    Werner JC; Sicard RE; Hansen TW; Solomon E; Cowett RM; Oh W
    J Pediatr; 1992 Feb; 120(2 Pt 1):286-91. PubMed ID: 1735831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrocortisone induced hypertrophic cardiomyopathy.
    Vimala J; Prabhu A; Pavithran S; Kumar RN
    Int J Cardiol; 2011 Aug; 150(3):e94-5. PubMed ID: 20045574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive drugs and hypertrophic cardiomyopathy.
    Brand PL; Brus F
    Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540240
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
    Röhr SB; Sauer H; Gortner L; Gräber S; Meyer S
    Acta Paediatr; 2013 Oct; 102(10):e436. PubMed ID: 23819647
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
    Ohning BL; Fyfe DA; Riedel PA
    Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemopericardium and cardiac tamponade as presenting findings of dexamethasone-induced hypertrophic cardiomyopathy complicated by transmural myocardial infarction.
    Lilien LD; Lilien RH; Setrakian S
    Pediatr Cardiol; 2003; 24(3):280-3. PubMed ID: 12632228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.